Estratest

WikiDoc Resources for Estratest

Articles

Most recent articles on Estratest

Most cited articles on Estratest

Review articles on Estratest

Articles on Estratest in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Estratest

Images of Estratest

Photos of Estratest

Podcasts & MP3s on Estratest

Videos on Estratest

Evidence Based Medicine

Cochrane Collaboration on Estratest

Bandolier on Estratest

TRIP on Estratest

Clinical Trials

Ongoing Trials on Estratest at Clinical Trials.gov

Trial results on Estratest

Clinical Trials on Estratest at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Estratest

NICE Guidance on Estratest

NHS PRODIGY Guidance

FDA on Estratest

CDC on Estratest

Books

Books on Estratest

News

Estratest in the news

Be alerted to news on Estratest

News trends on Estratest

Commentary

Blogs on Estratest

Definitions

Definitions of Estratest

Patient Resources / Community

Patient resources on Estratest

Discussion groups on Estratest

Patient Handouts on Estratest

Directions to Hospitals Treating Estratest

Risk calculators and risk factors for Estratest

Healthcare Provider Resources

Symptoms of Estratest

Causes & Risk Factors for Estratest

Diagnostic studies for Estratest

Treatment of Estratest

Continuing Medical Education (CME)

CME Programs on Estratest

International

Estratest en Espanol

Estratest en Francais

Business

Estratest in the Marketplace

Patents on Estratest

Experimental / Informatics

List of terms related to Estratest

Estratest is hormone replacement therapy drug that combines esterified estrogens with methyltestosterone in one pill.

## Contents

* 1 Indications
* 2 History
* 3 Dosage
* 4 Supply
* 5 Reference
* 6 External links

## Indications

[edit | edit source]

Estratest is used to treat menopausal women who suffer from hot flashes but do not get relief from estrogen-only therapy

## History

[edit | edit source]

Estratest was first marketed in the United States in 1965 by Reid-Provident Laboratories, which as 100% of Reid-Rowell, Inc. stock was acquired by the Belgian pharmaceutical company Solvay in 1986. There has been some controversy surrounding the drug in recent years as to its status with the FDA.

Solvay is currently sponsoring a clinical trial of Estratest in the United States to determine whether the product is superior to treatment with esterified estrogens tablets

## Dosage

[edit | edit source]

Estratest is sold in tablet form, with either 1.25 mg estrogens/2.5 mg methyltestosterone or 0.625 mg estrogens/1.25 mg methyltestosterone available.

## Supply

[edit | edit source]

Estratest is supplied by Solvay.

## Reference

[edit | edit source]

* August 2003 press release from the Prescription Access Litigation project [1].

## External links

[edit | edit source]

* The product's web site
* The clinical trial site

Template:WS Template:WH